MDT vs SN.L
MDT: Global medical device leader deploying pacemakers, defibrillators, spinal implants, surgical robotics, and diabetes management systems to alleviate pain, restore health, and extend life across 150+ countries. SN.L: A global medical technology leader focused on restoring patient mobility through advanced orthopedic, sports medicine, and wound care solutions.
Side-by-side fundamentals
| Metric | MDT | SN.L | Edge |
|---|---|---|---|
| Price as of 2026-08-05 close | $85.99 | £11.97 | |
| Market cap as of 2026-08-06 | $110.1B | n/a | |
| P/E as of 2026-08-06 | 22.90 | n/a | |
| PEG as of 2026-08-06 | 3.09 | n/a | |
| Net margin as of 2026-08-06 | +13.2% | n/a | |
| Gross margin as of 2026-08-06 | +65.3% | n/a | |
| Operating margin as of 2026-08-06 | +17.8% | n/a | |
| ROE as of 2026-08-06 | +9.8% | n/a | |
| ROA as of 2026-08-06 | +5.2% | n/a | |
| Debt / equity as of 2026-08-06 | 0.57 | n/a | |
| Revenue growth (YoY) as of 2026-08-06 | +8.4% | n/a | |
| Revenue CAGR (3y) SEC XBRL | +5.2% | n/a | |
| Dividend yield as of 2026-08-06 | +3.3% | n/a | |
| Dividend streak (yrs) SEC XBRL | 5 | n/a | |
| Beta as of 2026-08-06 | 0.56 | n/a | |
| 1-year return as of 2026-08-05 close | -4.1% | +3.5% | SN.L higher |
Fundamentals: market data, as of 2026-08-06. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-05.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.